SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-20-000073
Filing Date
2020-08-11
Accepted
2020-08-11 16:09:24
Documents
34
Period of Report
2020-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxearningsreleaseq2.htm 8-K 36660
2 EX-99.1 ex991-earningsreleaseq.htm EX-99.1 116414
3 EX-99.2 phasebiocorporateovervie.htm EX-99.2 57677
4 phasebio2020logo11.jpg GRAPHIC 27705
5 GRAPHIC phasebiocorporateovervie001.jpg GRAPHIC 64627
6 GRAPHIC phasebiocorporateovervie002.jpg GRAPHIC 201139
7 GRAPHIC phasebiocorporateovervie003.jpg GRAPHIC 164438
8 GRAPHIC phasebiocorporateovervie004.jpg GRAPHIC 131896
9 GRAPHIC phasebiocorporateovervie005.jpg GRAPHIC 35257
10 GRAPHIC phasebiocorporateovervie006.jpg GRAPHIC 101121
11 GRAPHIC phasebiocorporateovervie007.jpg GRAPHIC 57345
12 GRAPHIC phasebiocorporateovervie008.jpg GRAPHIC 121494
13 GRAPHIC phasebiocorporateovervie009.jpg GRAPHIC 41144
14 GRAPHIC phasebiocorporateovervie010.jpg GRAPHIC 136766
15 GRAPHIC phasebiocorporateovervie011.jpg GRAPHIC 92725
16 GRAPHIC phasebiocorporateovervie012.jpg GRAPHIC 111164
17 GRAPHIC phasebiocorporateovervie013.jpg GRAPHIC 116305
18 GRAPHIC phasebiocorporateovervie014.jpg GRAPHIC 113430
19 GRAPHIC phasebiocorporateovervie015.jpg GRAPHIC 127092
20 GRAPHIC phasebiocorporateovervie016.jpg GRAPHIC 130463
21 GRAPHIC phasebiocorporateovervie017.jpg GRAPHIC 116773
22 GRAPHIC phasebiocorporateovervie018.jpg GRAPHIC 103589
23 GRAPHIC phasebiocorporateovervie019.jpg GRAPHIC 106923
24 GRAPHIC phasebiocorporateovervie020.jpg GRAPHIC 51127
25 GRAPHIC phasebiocorporateovervie021.jpg GRAPHIC 95387
26 GRAPHIC phasebiocorporateovervie022.jpg GRAPHIC 108385
27 GRAPHIC phasebiocorporateovervie023.jpg GRAPHIC 92956
28 GRAPHIC phasebiocorporateovervie024.jpg GRAPHIC 102063
29 GRAPHIC phasebiocorporateovervie025.jpg GRAPHIC 108807
30 GRAPHIC phasebiocorporateovervie026.jpg GRAPHIC 137166
31 GRAPHIC phasebiocorporateovervie027.jpg GRAPHIC 47883
32 GRAPHIC phasebiocorporateovervie028.jpg GRAPHIC 142271
33 GRAPHIC phasebiocorporateovervie029.jpg GRAPHIC 121365
34 GRAPHIC phasebiocorporateovervie030.jpg GRAPHIC 57106
  Complete submission text file 0001169245-20-000073.txt   4576651
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 201092501
SIC: 2834 Pharmaceutical Preparations